ANBC, INC. (SYUP)

OTCMKTS · Delayed Price · Currency is USD

0.0003

+0.0001 (50.00%)

At close: Feb 25, 2026

-94.00% (1Y)

Market Cap	23.88K
Revenue (ttm)	50.95K
Net Income (ttm)	-382.25K
Shares Out	79.60M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	925
Average Volume	33,721
Open	0.0003
Previous Close	0.0002
Day's Range	0.0003 - 0.0003
52-Week Range	0.0001 - 0.0050
Beta	-6.15
RSI	41.47
Earnings Date	n/a

About ANBC, INC.

ANBC, INC. engages in the development, manufacturing, and commercialization of traditional Chinese herbal medicines and biological pharmaceuticals in the People’s Republic of China. Its products primarily include Qilisheng a product formulated to be a general health enhancer by fortifying the immune system; Qi-ju-di-huang, an oral solution that protects the kidney and the liver; Qing-re-jie-du, an oral solution that reduces fever and relieves heat; Sheng-mai-yin, a solution that protects energy and enhances body fluids; Xiao-qing-long, an oral ... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2003

Country United States

Stock Exchange OTCMKTS

Ticker Symbol SYUP

Full Company Profile

Financial Performance

In 2007, ANBC, INC.'s revenue was $50,946, a decrease of -83.70% compared to the previous year's $312,494. Losses were -$382,246, 18.2% more than in 2006.

News

There is no news available yet.